Korean J Transplant.  2022 Nov;36(Supple 1):S322. 10.4285/ATW2022.F-4589.

Renal cell carcinoma in pretransplant native nephrectomy of hemodialysis patient with acquired cystic kidney disease for deceased donor renal transplantation

• Shin BC
• Shin MH
• Yoon YM
• Kim HL
• Chung JH
• Choi NG

• KMID: 2535549
• DOI: http://doi.org/10.4285/ATW2022.F-4589

Abstract

The incidence of renal cell carcinoma is known to be higher in patients with end-stage renal disease, including those with acquired cystic kidney disease. Pretransplant native nephrectomy is performed to create space in the pelvis, to decrease compression by the enlarged polycystic kidney, and to prevent development of various symptoms. A 52-year-old man with end-stage kidney disease due to chronic glomerulonephritis planned to deceased donor kidney transplantation. Because of gallstone and enlarged polycystic kidneys, he underwent a cholecystectomy and bilateral nephrectomy. The tumor diameter of the left kidney was 2.6×1.5 cm. Pathology indicated multifocal renal cell carcinoma in both kidney with Fuhrman nuclear grade 1/4 and no lymphovascular invasion. This case reinforces the importance of considering the possibility of an occult malignancy in the native kidneys of patients with acquired cystic kidney disease. we present a case of incidental renal cell carcinoma in a patient with acquired cystic kidney disease who underwent bilateral native nephrectomy for deceased donor renal transplantation.